About This Review
This is Pfizer's first fully integrated Annual Review, providing a larger look at a number of dimensions of our performance—financial, environmental and social—in one review. It demonstrates the integral relationship between our responsibilities as an enterprise, and our core business strategies and their execution. It is produced for all of our stakeholders—patients, the medical community, investors, employees, customers and the public at large—to give a single picture of how we are doing, and, more importantly, how we are doing in delivering on our stated commitments.
Scope of Reporting
This review covers Pfizer's worldwide businesses, and provides information on our activities for the fiscal year ending on December 31, 2010. This review describes key dimensions of both the company's financial and nonfinancial performance, and includes updates on our present and planned products; our R&D pipeline; our commitment to quality, safety and high ethical standards; and our responsibilities to stakeholders, starting with our patients. This review also describes the most critical challenges to our sustainability—from expanding access to health to our environmental impact—and our strategy for managing them. Included for the first time are Key Performance Indicators that measure important dimensions of our nonfinancial performance and add to the total picture of how we did in 2010.
The print review provides a concise summary of our 2010 performance, while the Web version contains significant additional detail on our activities around the world.
Global Reporting Initiative Sustainability Reporting Guidelines
As global standards for integrated reporting do not exist, we considered the Global Reporting Initiative (GRI) Sustainability Reporting Guidelines (G3) in preparing this review. A comprehensive GRI Index can be found on our Web site www.pfizer.com/responsibility. We self-declare this review to GRI Application Level B.
Corporate Responsibility Management
This review was developed by Pfizer's Policy, External Affairs and Communications Division, whose leader is a member of executive leadership and reports directly to the CEO. Corporate responsibility is embedded in our business strategy and vision and many corporate responsibility issues are managed within our business units and functional groups to ensure deep integration in all of our work. The Corporate Responsibility team sets the strategic direction for corporate responsibility at Pfizer and supports the integration of corporate responsibility throughout the company.
In addition to strategy, the Corporate Responsibility team oversees the development of Pfizer's corporate responsibility reporting and communications, and manages engagement and partnerships with key civil society groups. The Corporate Responsibility team is also responsible for Pfizer's flagship global health philanthropic programs as part of its access strategy. Pfizer's Corporate Responsibility team provides updates to Pfizer's Board of Directors on specific progress toward corporate responsibility goals.
